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Background
Severe liver damage like cirrhosis and hepatocellular carci-
noma (HCC) can be caused by manifestation of the hepa-
titis C virus (HCV) infection. Constitutively activated
c-Myc oncogene has been shown to contribute to the
establishment of HCV-mediated HCC. Interestingly, only
one of many isoforms of the tumor suppressor protein
Bin1 (bridging integrator 1), Bin1+12A, contains an inter-
nal, canonical SH3 binding motif that recognizes its own
SH3 domain. This leads to the inability of Bin1+12A to
interact with c-Myc. The expression of the Bin1+12A iso-
form is a main phenotype in malignant melanoma cells.
We suggest that also other mechanisms that disturb the
interaction of Bin1 and c-Myc might have severe conse-
quences since the latter is tightly regulated in healthy cells.
The HCV nonstructural protein 5A (NS5A) plays a key
role in virus replication and assembly. NS5A plays an
intercepting role in several cellular pathways, which are
linked to cell growth, cell cycle control, cell survival, cellu-
lar stress response, apoptosis as well as HCC. It is known
that NS5A contains a highly conserved canonical, poly-
proline (PxxP) SH3-binding motif, which is located
between its D2 and D3 domains. This PxxP motif was
described to interact with the SH3 domain of Bin1. In
addition to a biophysical analysis of the canonical binding
between Bin1 SH3 and the PxxP motif of NS5A [1], we
identified two additional low-affinity binding sites for non-
canonical SH3 binding on NS5A [2]. The hypothesis
underlying the work presented here is that viral NS5A is
able to sequester cellular Bin1 from c-Myc.
Materials and methods
Expression and purification of Bin1 SH3 was done accord-
ing to published procedures [3]. NS5A(347-361) and c-Myc
(55-69) peptides were from GeneScript (USA) as reversed-
phase HPLC purified and mass spectroscopy confirmed
products. Fluorescence titration measurements were done,
and data were fitted as previously described [3]. To obtain
titration curves for deriving the binding constants, peptides
from stock solutions in the same buffer were added in
small increments to free SH3 domain (0.5 μM, 1x PBS with
2 mM DTT). Nuclear magnetic resonance (NMR) spectro-
scopy was performed using a Varian UnityINOVA NMR
spectrometer (Varian, Palo Alto, USA, 600 MHz proton
frequency, cryogenically cooled 5 mm Z-PFG-1H (13C,
15N)-probe head, 298 K). The peptides c Myc(55-69) and
NS5A(347-361) were added stepwise to free SH3 domain
(0.1 mM [U-15N]-Bin1 SH3, 1xPBS, 2 mM DTT, 10% (v/v)
deuterium oxide) until 1:1 ratios were reached. Competi-
tion experiments were conducted by adding c-Myc(55-69)
peptide to a preformed Bin1 SH3:NS5A(347-361) complex
and by adding NS5A(347-361) peptide to a preformed Bin1
SH3:c-Myc(55-69) complex until final ratios of 1:1:1 have
been reached. Spectra were processed (NMRPipe) and
analyzed (CcpNMR). New resonance signals of the Bin1
SH3:NS5A(347-361) complex were assigned using a 3D
HNCACB of [U-13C, U-15N]-Bin1 SH3 in complex with an
NS5A(333-369) peptide. The weighted chemical shift
changes upon interaction were calculated as described [3].
* Correspondence: si.hoffmann@fz-juelich.de; m.schwarten@fz-juelich.de
2Institute of Complex Systems (ICS-6) Structural Biochemistry,
Forschungszentrum Jülich, 52425 Jülich, Germany
Full list of author information is available at the end of the article
Aladağ et al. European Journal of Medical Research 2014, 19(Suppl 1):S10
http://www.eurjmedres.com/content/19/S1/S10 EUROPEAN JOURNAL 
OF MEDICAL RESEARCH
© 2014 Aladağ et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Results
Using fluorescence titration we calculated the dissocia-
tion constant (KD) as 0.2 ± 0.1 μM for the interaction
between Bin1 SH3 and NS5A(347-361), comprising the
core SH3 binding motif of NS5A. This value is consistent
with that for a longer NS5A(333-369) peptide determined
previously by surface plasmon resonance [1], and is
approximately 40-fold higher than the published value of
4.2 µM for the affinity between Bin1 SH3 and a 15-mer
c-Myc peptide (residues 55 to 69) comprising the c-Myc
SH3 binding side [4]. Our results suggest that an NS5A
derived peptide should be able to easily compete with the
c-Myc peptide for binding to Bin1 SH3.
Since the interaction surface of a protein as well as the
strength of an interaction can be defined by the observation
of its chemical shift perturbation (CSP) upon ligand bind-
ing, we measured (1H-15N)-HSQC spectra of [U-15N]-Bin1
SH3 either in the absence or in the presence of increasing c
Myc(55-69) concentrations. The spectra overlay clearly
shows a gradual chemical shift change indicating a fast
exchange regime of free and bound protein typical for low
affinity binding that is common for most SH3:ligand inter-
actions. In contrast, and consistent with the low KD mea-
sured by tryptophan fluorescence quenching, adding of
NS5A(347-361) to [U-15N]-Bin1 SH3 resulted in decreasing
intensities of the signals correlated with the free-state of
Bin1 SH3 accompanied with the appearance of new reso-
nance signals, which correspond to the Bin1 SH3:NS5A
(347-361) complex. This behavior is known to be typical
for slow complex dissociation observed for strong interac-
tions between a protein and a ligand. The different
exchange kinetics observed for the Bin1 SH3:NS5A(347-
361) complex and for the Bin1 SH3:c-Myc(55-69) complex
indicate a significantly higher affinity of the Bin1 SH3
domain to the peptide derived from NS5A than to that one
derived from c-Myc. To probe the competing potential of
NS5A, we performed an additional (1H-15N)-HSQC experi-
ment and added NS5A(347-361) to an existing Bin1 SH3:
c-Myc(55-69) complex in solution. Comparison of this
spectrum with the spectrum of the Bin1 SH3:NS5A(347-
361) complex revealed that both spectra are virtually identi-
cal, a fact, which can be explained by a NS5A(347-361)
mediated displacement of c-Myc(55-69) from the Bin1 SH3
binding surface.
Finally, we combined our CSP data with own unpub-
lished assignment data and those of PDB entry for free
Bin1 SH3 (PDB: 1MUZ) to visualize the binding interfaces
of NS5A(347-361) and c-Myc(55-69) with Bin1 SH3. As
expected both peptides follow the canonical PxxP-ligand
binding mode, and interact via Bin1 SH3 residues in the
RT loop, the C-terminal region of the n-Src loop and
b-strands 4 and 5. Bin1 SH3 domain is one of most nega-
tively charged SH3 domains, and several of these residues
are located in the Bin1 SH3 binding interface. Thereby,
the negatively charged aspartate residues 535 and 537 in
the RT-loop, which are unique for the Bin1 SH3 domain,
seem to be the main determinants for the NS5A:Bin1 SH3
interaction. This probably explains why ligands with many
positive residues such as NS5A can be bound by Bin1 SH3
with the observed extraordinary high specificity and
affinity.
Conclusions
Typically, the interaction between a cellular SH3 domain
and a cellular ligand is transient and the respective affinity
is in the high to low micromolar range. Hence, SH3
domains usually are optimized to be able to choose
between many cellular partners of diverse cellular pathways
in respect to the cellular needs and environmental factors.
Our data show that a short peptide comprising the canoni-
cal PxxP binding motif located inside the low complexity
sequence 2 region of NS5A is able to easily compete with a
c-Myc-derived peptide resembling the physiologic Bin1
SH3 binding site of c-Myc in vitro. This provides first
insights into not yet recognized activities of the HCV
NS5A protein. We suggest that NS5A might have the
potency to negatively influence the SH3 mediated tumor
suppressor qualities of Bin1 also in vivo, e.g. by enhancing
the levels of free and activated c-Myc molecules inside
HCV infected cells.
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